MEDVi is a telemedicine platform focused on medical weight loss, offering personalized treatment plans with GLP-1 medications, such as semaglutide, to help individuals manage weight more effectively than diet and exercise alone.
The process starts with a quick online medical evaluation to determine eligibility. If approved, patients receive a customized prescription and ongoing medical support. Medications are delivered directly to the patient’s home, with no insurance required.
MEDVi highlights:
Care provided by licensed U.S. medical professionals
Simple monthly plans with transparent pricing
Continuous support throughout the treatment
A focus on appetite control and metabolic health
The platform is designed for people looking for a convenient, doctor-guided weight loss solution without in-person clinic visits.
Individual results may vary, and participation depends on medical approval.